文献速递核素与放射性配体治疗放射性药物与辐射防护

使用MAGIC-f聚合物凝胶剂量计评估90Y-SIRT与SBRT联合治疗中端到端3D吸收剂量分布

Evaluation of end-to-end 3D absorbed dose distribution in 90Y-SIRT and SBRT combination therapy using MAGIC-f polymer gel dosimeter.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2025-08-08

本研究用MAGIC-f聚合物凝胶剂量计在体外实验中测量外照射放疗、90Y-SIRT及两者联合治疗的3D吸收剂量分布,并在模拟肝内肿瘤的体模中验证联合治疗剂量。凝胶在EBRT和联合治疗照射范围内呈线性剂量响应,90Y-SIRT线性范围为0至16.75 Gy;体模球体内联合治疗平均吸收剂量为18.58 Gy,凝胶法较PET/CT剂量学具有更优空间分辨率,可用于复杂剂量分布的客观物理验证。

要点

  • MAGIC-f凝胶在EBRT和联合治疗照射范围内剂量响应呈线性,90Y-SIRT线性范围为0至16.75 Gy。
  • 体模球体内平均吸收剂量:SBRT 9.83 Gy、SIRT 9.71 Gy、联合治疗18.58 Gy。
  • 联合治疗的DVH、线剖面和等剂量线显示两种治疗吸收剂量的累积效应。

核心结论

  • 本研究首次证明用MAGIC-f凝胶剂量计直接测量90Y-SIRT与SBRT联合治疗3D剂量分布的可行性。
  • 与基于PET/CT的剂量学相比,凝胶法具有更优的空间分辨率,可对复杂剂量分布进行客观物理验证。
  • 该技术在诊疗一体化方案的质量保证方面具有较强潜力,尤其适用于β发射体,未来也可能用于α发射放射性示踪剂。

研究设计与样本

  • 体外实验研究,使用MAGIC-f聚合物凝胶剂量计进行外照射放疗、90Y-SIRT和联合治疗三组实验。
  • 外照射放疗:8个装有凝胶的校准瓶接受0至21 Gy吸收剂量照射。
  • 90Y-SIRT:11个装有含不同浓度90Y-柠檬酸盐凝胶的瓶,68小时后递送0至44 Gy剂量。
  • 联合治疗:8个瓶先接受90Y-柠檬酸盐68小时后0至7 Gy照射,再接受SBRT追加0至7 Gy(最终剂量0至14 Gy)。
  • 体模模拟正常肝脏内肿瘤,球体经SIRT 68小时后接受10 Gy、再经6MV光子SBRT接受10 Gy(总计20 Gy);SBRT前进行PET/CT成像,采用MIRD方案计算剂量;每次实验用3特斯拉扫描仪行MR T2加权成像并分析R2图(1/s)。

主要发现

  • 凝胶剂量响应在EBRT和联合治疗的照射范围内呈线性;90Y-SIRT的线性范围为0至16.75 Gy。
  • 凝胶灵敏度分别为EBRT 0.380 s⁻¹/Gy、90Y-SIRT 0.758 s⁻¹/Gy、联合治疗实验0.713 s⁻¹/Gy。
  • 联合治疗体模中球体中心核心出现饱和区,周围为直径4.5 mm的低估区。
  • 球体内平均吸收剂量:SBRT 9.83 Gy、SIRT 9.71 Gy、联合治疗18.58 Gy;圆柱体相应值分别为1.29 Gy、0.61 Gy、2.68 Gy。
  • 联合治疗的DVH、线剖面和等剂量线显示两种治疗吸收剂量的累积效应。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Selective Internal Radiation Therapy (SIRT) with 90Y-microspheres, and Stereotactic Body Radiation Therapy (SBRT), are well-established treatment strategies for liver malignancies. Combining these two modalities has proven to be an effective and safe approach for addressing undertreated tumor regions from initial SIRT through a boost dose from SBRT. The complex dosimetry process, which includes image-based dosimetry of 90Y-SIRT and SBRT dose painting, requires precise dosimetry verification. In this study, gel dosimetry is proposed as a valuable novel tool to capture the 3D absorbed dose contributions from both treatments with high spatial resolution. METHODS: The MAGIC-f polymer gel dosimeter was used in three experiments: external beam radiation therapy (EBRT), 90Y-SIRT, and combination therapy. For EBRT, eight calibration vials filled with gel were irradiated with absorbed doses ranging from 0 to 21 Gy. In the 90Y-SIRT experiments, eleven vials were filled with gel containing varying concentrations of 90Y-citrate, delivering doses from 0 to 44 Gy after 68 h. For combination therapy, eight vials received 0-7 Gy from 90Y-citrate after 68 h, followed by an additional 0-7 Gy from SBRT (final doses 0-14 Gy). A phantom, designed to simulate a tumor within a normal liver, was created with the sphere receiving 10 Gy after 68 h from SIRT and another 10 Gy from SBRT using 6MV photons (in total 20 Gy). PET/CT imaging was conducted before SBRT, and the Medical Internal Radiation Dose (MIRD) schema was used for dose calculations. For each experiment, MR T2-weighted imaging was performed using a 3 Tesla scanner, and R2 maps (1/s) were analyzed to establish a dose-response relationship between absorbed dose (Gy) and R2. The gel's sensitivity to each irradiation was measured, and phantom's dose maps were evaluated using mean absorbed dose, dose volume histograms (DVHs), line profiles, and isodose maps. RESULTS: The dose response of the gel was linear within the irradiated ranges for EBRT and combination therapy. The linear range for 90Y-SIRT was between 0 and 16.75 Gy. The sensitivity of the gel was 0.380, 0.758, and 0.713 s⁻¹/Gy for EBRT, 90Y-SIRT, and combination experiments, respectively. In the phantom irradiated with combination therapy, a saturated area was observed in the central core of the sphere, surrounded by an underestimation area with a diameter of 4.5 mm. The mean absorbed dose values within the sphere were 9.83 Gy, 9.71 Gy, and 18.58 Gy from SBRT, SIRT, and combination therapy, respectively. For the cylinder, these values were 1.29 Gy, 0.61 Gy, and 2.68 Gy, respectively. The DVHs, line profiles, and isodose lines for the combination therapy demonstrated the cumulative effects of the absorbed dose from both treatments. CONCLUSION: This is the first study demonstrating the feasibility of using MAGIC-f gel dosimetry to directly measure 3D dose distributions from combined 90Y-SIRT and SBRT. Compared to PET/CT-based dosimetry, the gel method offers superior spatial resolution and enables objective physical verification of complex dose distributions. This technique has strong potential for quality assurance in theranostic protocols, particularly for beta emitters and, potentially, alpha-emitting radiotracers in future applications.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Mansouri Z, Salimi Y, Koutsouvelis N, et al. Evaluation of end-to-end 3D absorbed dose distribution in 90Y-SIRT and SBRT combination therapy using MAGIC-f polymer gel dosimeter. Eur J Nucl Med Mol Imaging. 2025. PMID: 40779067. doi:10.1007/s00259-025-07461-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。